Wolfgang Singer Selected Research

Wolfgang Singer Research Topics

Disease

14	Multiple System Atrophy 01/2021 - 04/2012
10	Orthostatic Hypotension (Postural Hypotension) 01/2022 - 02/2005
7	Synucleinopathies 01/2021 - 10/2019
6	Parkinson Disease (Parkinson's Disease) 01/2022 - 05/2008
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 04/2012
3	Pure Autonomic Failure 01/2021 - 02/2017
3	Autonomic Nervous System Diseases (Dysautonomia) 01/2020 - 05/2008
3	Dementia (Dementias) 01/2020 - 02/2017
3	Hypertension (High Blood Pressure) 05/2008 - 02/2005
2	Disease Progression 01/2022 - 02/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2019
2	Hypohidrosis 01/2020 - 10/2018
2	Parkinsonian Disorders (Parkinsonism) 12/2019 - 04/2012
2	Peripheral Nervous System Diseases (PNS Diseases) 09/2016 - 12/2014
2	Cerebellar Ataxia (Dysmetria) 12/2014 - 04/2012
2	Postural Orthostatic Tachycardia Syndrome 10/2014 - 05/2008
1	Obesity 11/2021
1	Hypertriglyceridemia 11/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2021
1	Fabry Disease (Fabry's Disease) 11/2021
1	Amyloid Plaque 01/2021
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021
1	Constipation 01/2021
1	Dyspepsia (Indigestion) 01/2020
1	Ulcer 01/2020
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2019
1	Gastroparesis 01/2019
1	Diabetes Mellitus 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2019
1	Respiratory Sounds (Crackle) 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Anemia 01/2018
1	REM Sleep Behavior Disorder 02/2017
1	Amyloidosis 09/2016
1	Amyloid Neuropathies (Amyloid Neuropathy) 09/2016
1	Spastic ataxia Charlevoix-Saguenay type 12/2014
1	Dysarthria (Spastic Dysarthria) 12/2014
1	Ataxia (Dyssynergia) 12/2014
1	Myasthenia Gravis 05/2008
1	Orthostatic Intolerance 10/2006

Drug/Important Bio-Agent (IBA)

6	SynucleinsIBA 01/2022 - 03/2014
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2015
5	hydroxide ionIBA 10/2019 - 04/2006
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022 - 02/2017
3	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 05/2008 - 02/2005
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 10/2014
2	Amyloid (Amyloid Fibrils)IBA 11/2021 - 09/2016
2	Prealbumin (Transthyretin)IBA 11/2021 - 09/2016
2	alpha-SynucleinIBA 01/2021 - 01/2020
2	VaccinesIBA 01/2020 - 01/2020
2	Rifampin (Rifampicin)FDA LinkGeneric 02/2015 - 03/2014
2	AcetylcholinesteraseIBA 05/2008 - 10/2006
2	Pharmaceutical PreparationsIBA 05/2008 - 04/2006
1	Poly Adenosine Diphosphate RiboseIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 11/2021
1	NucleotidesIBA 01/2021
1	Coenzyme A (CoA)IBA 01/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	tributyl phosphate (TBP)IBA 01/2021
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2021
1	Biological ProductsIBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	exendin (9-39)IBA 01/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019
1	6-chloropenicillanic acid S-sulfoxideIBA 10/2018
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	Retinaldehyde (Retinal)IBA 12/2014
1	Levodopa (L Dopa)FDA LinkGeneric 04/2012
1	AntibodiesIBA 05/2008
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2008
1	Midodrine (Midon)FDA LinkGeneric 04/2006

Therapy/Procedure

4	Therapeutics 01/2021 - 03/2014
1	Bed Rest (Bedrest) 01/2018
1	Polypharmacy 01/2018
1	Activities of Daily Living (ADL) 07/2015